BACKGROUND: Encapsulating peritoneal sclerosis (EPS) and simple peritoneal sclerosis are important complications of long-term peritoneal dialysis (PD). Podoplanin is expressed by mesothelial cells and lymphatic vessels, which are involved in inflammatory reactions in the peritoneal cavity. METHODS: We studied 69 peritoneal biopsies from patients on PD (n = 16), patients with EPS (n = 18) and control biopsies taken at the time of hernia repair (n = 15) or appendectomy (n = 20). Immunohistochemistry was performed to localize podoplanin. Additionally, markers of endothelial cells, mesothelial cells, myofibroblasts (smooth muscle actin), proliferating cells, and double labelling for smooth muscle actin/podoplanin were used on selected biopsies. RESULTS: Podoplanin was present on the endothelium of lymphatic vessels in the submesothelial fibrous tissue and on mesothelial cells. In patients on PD and in biopsies with appendicitis, the mesothelial cells demonstrated a cuboidal appearance and circumferential podoplanin staining, with gaps between the cells. The number of lymphatic vessels was variable, but prominent at sites of fibrosis. In patients with EPS, a diffuse infiltration of podoplanin-positive cells with a fibroblastic appearance was present in 15 out of 18 biopsies. This pattern was focally present in 3 out of 16 on PD and none in the 35 controls. The podoplanin-positive cells did not express the endothelial marker or the mesothelial marker (calretinin). CONCLUSIONS: EPS is characterized by a population of podoplanin and smooth muscle actin double-positive cells. Podoplanin might be a suitable morphological marker supporting the diagnosis and might be involved in the pathogenesis of EPS.
BACKGROUND: Encapsulating peritoneal sclerosis (EPS) and simple peritoneal sclerosis are important complications of long-term peritoneal dialysis (PD). Podoplanin is expressed by mesothelial cells and lymphatic vessels, which are involved in inflammatory reactions in the peritoneal cavity. METHODS: We studied 69 peritoneal biopsies from patients on PD (n = 16), patients with EPS (n = 18) and control biopsies taken at the time of hernia repair (n = 15) or appendectomy (n = 20). Immunohistochemistry was performed to localize podoplanin. Additionally, markers of endothelial cells, mesothelial cells, myofibroblasts (smooth muscle actin), proliferating cells, and double labelling for smooth muscle actin/podoplanin were used on selected biopsies. RESULTS:Podoplanin was present on the endothelium of lymphatic vessels in the submesothelial fibrous tissue and on mesothelial cells. In patients on PD and in biopsies with appendicitis, the mesothelial cells demonstrated a cuboidal appearance and circumferential podoplanin staining, with gaps between the cells. The number of lymphatic vessels was variable, but prominent at sites of fibrosis. In patients with EPS, a diffuse infiltration of podoplanin-positive cells with a fibroblastic appearance was present in 15 out of 18 biopsies. This pattern was focally present in 3 out of 16 on PD and none in the 35 controls. The podoplanin-positive cells did not express the endothelial marker or the mesothelial marker (calretinin). CONCLUSIONS:EPS is characterized by a population of podoplanin and smooth muscle actin double-positive cells. Podoplanin might be a suitable morphological marker supporting the diagnosis and might be involved in the pathogenesis of EPS.
Authors: Harald Seeger; Joerg Latus; Daniel Kitterer; M Dominik Alscher; Dagmar Biegger; Jin Chen; Ilka Edenhofer; Rudolf P Wüthrich; Stephan Segerer Journal: Clin Exp Nephrol Date: 2017-05-27 Impact factor: 2.801
Authors: Rusan Catar; Janusz Witowski; Nan Zhu; Christian Lücht; Alicia Derrac Soria; Javier Uceda Fernandez; Lei Chen; Simon A Jones; Ceri A Fielding; Andras Rudolf; Nicholas Topley; Duska Dragun; Achim Jörres Journal: J Am Soc Nephrol Date: 2016-11-11 Impact factor: 10.121
Authors: Joerg Latus; Christoph Ulmer; Peter Fritz; Bianka Rettenmaier; Dagmar Biegger; Thomas Lang; German Ott; Martin Kimmel; Wolfgang Steurer; M Dominik Alscher; Stephan Segerer; Niko Braun Journal: Perit Dial Int Date: 2013-02-01 Impact factor: 1.756
Authors: Niko Braun; Kontheari Sen; M Dominik Alscher; Peter Fritz; Martin Kimmel; Johann Morelle; Eric Goffin; Achim Jörres; Rudolf P Wüthrich; Clemens D Cohen; Stephan Segerer Journal: Perit Dial Int Date: 2013-02-01 Impact factor: 1.756
Authors: Niko Braun; Peter Fritz; Christoph Ulmer; Joerg Latus; Martin Kimmel; Dagmar Biegger; German Ott; Fabian Reimold; Klaus-Peter Thon; Juergen Dippon; Stephan Segerer; M Dominik Alscher Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240
Authors: Fabian R Reimold; Niko Braun; Zsuzsanna K Zsengellér; Isaac E Stillman; S Ananth Karumanchi; Hakan R Toka; Joerg Latus; Peter Fritz; Dagmar Biegger; Stephan Segerer; M Dominik Alscher; Manoj K Bhasin; Seth L Alper Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240
Authors: Niko Braun; M Dominik Alscher; Peter Fritz; Joerg Latus; Ilka Edenhofer; Fabian Reimold; Seth L Alper; Martin Kimmel; Dagmar Biegger; Maja Lindenmeyer; Clemens D Cohen; Rudolf P Wüthrich; Stephan Segerer Journal: PLoS One Date: 2012-12-31 Impact factor: 3.240